Last updated on November 2017

Dust Mite Allergy Study


Brief description of study

Dust Mite Allergy Study

Detailed Study Description

Study for individuals with a house dust mite allergy ages 12 to 65. Study medication is a tablet form of immunotherapy. Standard immunotherapy is allergy shots. This study does not use allergy shots, but is a sublingual tablet that dissolves under the tongue specific for dust mite allergy. Study lasts 14 to 20 months with 10 visits to our office. Successfully enrolled participants may receive study medication and will receive rescue medication to treat symptoms of allergic rhinitis at no charge. Study related physical exams, allergy testing, and lab work will be provided at no charge. Time and travel will be reimbursed.

Clinical Study Identifier: TX15198

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Karen Towner, BSN, RN

AAIR Research Center
Rochester, NY USA
  Connect »